Literature DB >> 8759807

Regional cardiac sympathetic nerve dysfunction and the diagnostic efficacy of metaiodobenzylguanidine tomography in stable coronary artery disease.

T Nakata1, K Nagao, K Tsuchihashi, A Hashimoto, S Tanaka, O Iimura.   

Abstract

The present study endeavors to correlate regional myocardial sympathetic nerve dysfunction with reversible and persistent perfusion abnormalities and depressed regional wall motion, and to determine the diagnostic efficacy of radio-iodinated metaiodobenzylguanidine (MIBG) tomography for detecting coronary artery disease. In 28 consecutive patients with stable coronary artery disease and 7 patients with atypical chest pain but no coronary stenosis, regional MIBG uptake was semiquantitatively evaluated in 13 left ventricular segments early (30 minutes) and late (4 hours) after injection. Regional MIBG uptake was reduced in 68 of 90 segments (76%) showing reversible perfusion abnormality and 72 of 81 segments (89%) showing persistent abnormality 4 hours after injection. Although the sensitivity and negative predictive values of late MIBG scanning for detecting myocardial perfusion abnormalities were relatively high (82% and 85%, respectively), the specificity, positive predictive value, and kappa value were low (63%, 57%, and 0.41, respectively). Right coronary lesions were detected by late MIBG scanning with a high sensitivity (85%) but a low specificity (41%). Conversely, the sensitivities for detecting lesions in the other 2 major left coronary arteries were low (55%). The overall diagnostic accuracy of late MIBG scanning was 66% and the positive and negative predictive values and kappa value were low; 60%, 70%, and 0.31, respectively. Similarly, regional sympathetic dysfunction was observed in 42 of 49 asynergic segments (86%) on late MIBG scans, of which 32 segments were viable and 10 nonviable; but the low specificity (73%) and positive predictive value (44%) reduced the kappa value (0.43). Thus, regional cardiac sympathetic innervation is impaired in ischemic, asynergic but noninfarcted myocardium as well as in myocardium which is infarcted or has a persistent perfusion abnormality. The diagnostic efficacy of MIBG tomography to detect coronary artery disease, however, is limited probably because of nonspecific reductions of MIBG uptake in the inferior and posterolateral regions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8759807     DOI: 10.1016/s0002-9149(96)00280-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  Cardiac neurotransmission SPECT imaging.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

2.  123I-MIBG myocardial scintigraphy as a noninvasive screen for the diagnosis of coronary artery spasm.

Authors:  J W Ha; J D Lee; Y Jang; N Chung; J Kwan; S J Rim; Y J Lee; W H Shim; S Y Cho; S S Kim
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

3.  Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts.

Authors:  T Nakata; K Miyamoto; A Doi; H Sasao; T Wakabayashi; H Kobayashi; K Tsuchihashi; K Shimamoto
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

Review 4.  Abnormal cardiac nerve function in syndrome X.

Authors:  G A Lanza
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

Review 5.  Complementary Role of Combined Indirect and Direct Cardiac Sympathetic (Hyper)Activity Assessment in Patients with Heart Failure by Spectral Analysis of Heart Rate Variability and Nuclear Imaging: Possible Application in the Evaluation of Exercise Training Effects.

Authors:  Ferdinando Iellamo; Marco Alfonso Perrone; Andrea Cimini; Giuseppe Caminiti; Agostino Chiaravalloti; Attilio Parisi; Orazio Schillaci
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-05

Review 6.  Cardiac metaiodobenzylguanidine imaging and heart failure.

Authors:  Tomoaki Nakata; Akiyoshi Hashimoto; Hirohito Sugawara
Journal:  Curr Heart Fail Rep       Date:  2013-12

7.  Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure.

Authors:  Tomoaki Nakata; Takeru Wakabayashi; Michifumi Kyuma; Toru Takahashi; Kazufumi Tsuchihashi; Kazuaki Shimamoto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-25       Impact factor: 9.236

Review 8.  Cardiac autonomic imaging with SPECT tracers.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2013-02       Impact factor: 5.952

9.  Cardiac 123I-MIBG normal uptake values are population-specific: Results from a cohort of controls over 60 years of age.

Authors:  G Roberts; J J Lloyd; J P M Kane; R Durcan; S Lawley; K Howe; G S Petrides; J T O'Brien; A J Thomas
Journal:  J Nucl Cardiol       Date:  2019-09-16       Impact factor: 5.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.